New York City Icahn School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study and “CBD International...
MediPharm Labs Australia Awarded Cannabis Manufacturing Licence From Office of Drug Control – Establishes Asia-Pacific Foothold TORONTO, May 21, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX:...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$5.0 million per quarter. This...
Emerald’s ultra-pure SYNC 25 CBD oil fills significant need in BC’s recreational marketplace, offering a non-THC, smoke-free alternative VANCOUVER, British Columbia, May 17, 2019 (GLOBE NEWSWIRE) — Emerald Health...
Financing to Support Accelerated Growth TORONTO, May 15, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid...
Cronos Group and MediPharm Labs Enter $30 Million Multi-Year Private Label Cannabis Concentrate Supply Agreement with Potential to Increase to $60 Million Cronos Group and MediPharm Labs Enter Additional...
This is a copy of the May 12th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, “The next Tilray”. This was a phrase...
MediPharm Labs Announces Q1 2019 Revenue of $22 Million and Adjusted EBITDA of $4.3 Million TORONTO, May 10, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF)...
After a 57.4% rebound in Q1, Cannabis stocks, as measured by the Global Cannabis Stock Index, gave up some ground in April, declining 1.5%: The index, which had 64 qualifying...
After a 54.9% gain in Q1, the Canadian Cannabis LP Index backtracked marginally in April, declining 0.9% to 1081.95: The index remains substantially below the all-time closing high of 1289.57 on October...
TORONTO, May 02, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...
New Pharma Executive Position Created to Advance Corporate Strategy, Global Growth and Strategic Partnerships TORONTO, April 29, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) (FSE:...
The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than US$2.5 million per quarter. This...
TORONTO, April 09, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...
TORONTO, April 08, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction,...
This is a copy of the April 7th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, As we shared at the beginning of...
MediPharm Labs Reports Q4 2018 Revenue of $10.2 Million and Adjusted EBITDA of $2.1 Million TORONTO, April 03, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF)...
Over the balance of this week as well as during next week, several cannabis companies will be reporting quarterly financials, with some of them announcing the pending releases and,...
After sinking 43.8% in Q4, the Canadian Cannabis LP Index extended its January rally, rising 4.2% in February to 997.94: The index, up 41.6% to begin 2019, is still down substantially from...
This is a copy of the February 24th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, On Friday, Statistics Canada provided its monthly...
MediPharm Labs Becomes First Extraction Only Licensed Producer to Begin Global Export TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm Labs”),...
TORONTO, Feb. 19, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (FSE:MLZ) (“MediPharm”) a leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is...
This is a copy of the February 17th edition of our weekly Newsletter, which we have been publishing since October 2015. Friends, As Canada’s legal cannabis industry continues to...
MediPharm Labs Signs $35 Million Private Label Cannabis Oil Sale Agreement with Option for Additional $13.5 Million TORONTO, Feb. 12, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV:...
TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSXV: LABS) (OTCQB: MLCPF) (the “Company” or “MediPharm Labs”) the leader in specialized, research-driven cannabis extraction, is pleased to...
